ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
TRT can delay CKD
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Will Brink" data-source="post: 69593" data-attributes="member: 2074"><p>interesting finding here, TRT delay progression of chronic kidney disease:</p><p></p><p>Testosterone replacement therapy (TRT) may delay progression of chronic kidney disease (CKD) and lower the risk of death in men with hypogonadism, new findings presented at the National Kidney Foundation's 2017 Spring Clinical Meetings suggest.</p><p></p><p>Archana Goel, MD, of the Veterans Administration Medical Center in Kansas City, Missouri, and colleagues analyzed data from a large cohort of veterans diagnosed with low total testosterone (TT). The investigators divided patients into 2 groups: those treated and who had normalization of TT (38,708 men) and those who were not treated (9755 men) and continued to have low TT. The treated and untreated groups had follow-up times of 6.1 and 5.1 years, respectively.</p><p></p><p>The groups did not differ significantly in the number of days until patients had a 30% or greater increase in serum creatinine or doubling of serum creatinine from baseline, the investigators reported in a poster presentation. The treated group, however, showed a significant delay in the progression of CKD as measured by days to serum creatinine increases of 1.5 or higher and 3.0 mg/dL or higher. TRT delayed the time to end-stage renal disease (ESRD), as defined by a serum creatinine level greater than 6.0 mg/dL) by 284 days and time to death by 328 days. Compared with the untreated men, the treated men had a 24% decreased risk of ESRD and 25% decreased risk of death.</p><p></p><p>Dr Goel's group concluded that “TRT does not associate with significant disadvantages at earlier stages of CKD, but rather a significant decrease and delay in all-cause mortality and delay in progression toward ESRD.”</p><p></p><p>Cont:</p><p></p><p><a href="http://www.renalandurologynews.com/nkf-2017-spring-meeting/chronic-kidney-disease-progression-delayed-with-testosterone-therapy/article/651738/?DCMP=EMC-RUN_TodaysUpdate_20170422&cpn&NID&hmSubId=VNmBBvKiCFI1&spMailingID=17064706&spUserID=MTE3Mzk5MDYzODAyS0&spJobID=1001805288&spReportId=MTAwMTgwNTI4OAS2" target="_blank">http://www.renalandurologynews.com/nkf-2017-spring-meeting/chronic-kidney-disease-progression-delayed-with-testosterone-therapy/article/651738/?DCMP=EMC-RUN_TodaysUpdate_20170422&cpn&NID&hmSubId=VNmBBvKiCFI1&spMailingID=17064706&spUserID=MTE3Mzk5MDYzODAyS0&spJobID=1001805288&spReportId=MTAwMTgwNTI4OAS2</a></p></blockquote><p></p>
[QUOTE="Will Brink, post: 69593, member: 2074"] interesting finding here, TRT delay progression of chronic kidney disease: Testosterone replacement therapy (TRT) may delay progression of chronic kidney disease (CKD) and lower the risk of death in men with hypogonadism, new findings presented at the National Kidney Foundation's 2017 Spring Clinical Meetings suggest. Archana Goel, MD, of the Veterans Administration Medical Center in Kansas City, Missouri, and colleagues analyzed data from a large cohort of veterans diagnosed with low total testosterone (TT). The investigators divided patients into 2 groups: those treated and who had normalization of TT (38,708 men) and those who were not treated (9755 men) and continued to have low TT. The treated and untreated groups had follow-up times of 6.1 and 5.1 years, respectively. The groups did not differ significantly in the number of days until patients had a 30% or greater increase in serum creatinine or doubling of serum creatinine from baseline, the investigators reported in a poster presentation. The treated group, however, showed a significant delay in the progression of CKD as measured by days to serum creatinine increases of 1.5 or higher and 3.0 mg/dL or higher. TRT delayed the time to end-stage renal disease (ESRD), as defined by a serum creatinine level greater than 6.0 mg/dL) by 284 days and time to death by 328 days. Compared with the untreated men, the treated men had a 24% decreased risk of ESRD and 25% decreased risk of death. Dr Goel's group concluded that “TRT does not associate with significant disadvantages at earlier stages of CKD, but rather a significant decrease and delay in all-cause mortality and delay in progression toward ESRD.” Cont: [url]http://www.renalandurologynews.com/nkf-2017-spring-meeting/chronic-kidney-disease-progression-delayed-with-testosterone-therapy/article/651738/?DCMP=EMC-RUN_TodaysUpdate_20170422&cpn&NID&hmSubId=VNmBBvKiCFI1&spMailingID=17064706&spUserID=MTE3Mzk5MDYzODAyS0&spJobID=1001805288&spReportId=MTAwMTgwNTI4OAS2[/url] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
TRT can delay CKD
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top